BIOENSIS offers a streamlined and systematic platform to screen anti-cancer agents across a diverse panel of tumor-derived cell lines. Utilizing both 2D and 3D culture systems grown under physiologically relevant conditions, our service enhances the predictive value of in vitro testing and supports confident candidate selection for further development—helping reduce the risk of late-stage failure.
Key Features:
• Profile compounds against up to 150 tumor cell lines, covering a wide range of cancer types and subtypes
• Single-agent or combination testing in quadruplicate, across nine-point concentration curves
• Fully automated 384-well platform for efficiency and consistency
• Precision IC50, EC50, and GI50 results
• Available in both 2D and 3D formats to suit your experimental needs
Please contact us to discuss your study and an up to date list of available cell lines
info@bioensis.com
